Method for in-vitro differentiation from induced pluripotent stem cells to oocyte stagnating in meiosis II stage
A technology of human pluripotent stem cells and meiosis, applied in the field of cell engineering, can solve the problems of time-consuming and low efficiency, and achieve the effect of high efficiency and short time.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] A method for inducing human pluripotent stem cells to differentiate in vitro into oocytes arrested in meiosis II, comprising the following steps:
[0043] (1) Inducing human pluripotent stem cells to form primordial germ cell-like cells: inoculate pluripotent stem cells into PGC-m medium, 2 Cultured under conditions for 10 days to obtain primordial germ cell-like cells (iPGC), the medium was replaced every day during the culture; the PGC-m medium was α-MEM medium supplemented with 5% KSR and 5% bFF, Moreover, the following components are also added to the PGC-m medium:
[0044] 1% L-glutamine, 1% non-essential amino acids, 0.1 mM b-mercaptoethanol, 1% penicillin, 50 ng / mL bone morphogenetic protein, 200 ng / mL leukocyte inhibitory factor, 100 ng / mL stem cells factor, 50ng / mL epidermal growth factor and 10μmol / L ROCK inhibitor;
[0045] (2) Inducing primordial germ cells to form a follicle-like structure: transfer the primordial germ cells induced in step (1) to PF-m me...
Embodiment 2
[0050] A method for inducing human pluripotent stem cells to differentiate in vitro into oocytes arrested in meiosis II, comprising the following steps:
[0051] (1) Inducing human pluripotent stem cells to form primordial germ cell-like cells: inoculate pluripotent stem cells into PGC-m medium, 2 Cultured under conditions for 10 days to obtain primordial germ cell-like cells (iPGC), the medium was replaced every day during the culture; the PGC-m medium was α-MEM medium supplemented with 3% KSR and 6% bFF, Moreover, the following components are also added to the PGC-m medium:
[0052] 0.5% L-glutamine, 2% non-essential amino acids, 0.15mM b-mercaptoethanol, 1.5% penicillin, 40ng / mL bone morphogenetic protein, 250ng / mL leukocyte inhibitory factor, 80ng / mL stem cells Factor, 60ng / mL epidermal growth factor and 5μmol / L ROCK inhibitor;
[0053] (2) Inducing primordial germ cells to form a follicle-like structure: transfer the primordial germ cells induced in step (1) to PF-m med...
Embodiment 3
[0058] A method for inducing human pluripotent stem cells to differentiate in vitro into oocytes arrested in meiosis II, comprising the following steps:
[0059] (1) Inducing human pluripotent stem cells to form primordial germ cell-like cells: inoculate pluripotent stem cells into PGC-m medium, 2 Cultured under conditions for 10 days to obtain primordial germ cell-like cells (iPGC), the medium was replaced every day during the culture; the PGC-m medium was α-MEM medium supplemented with 6% KSR and 3% bFF, Moreover, the following components are also added to the PGC-m medium:
[0060] 2% L-glutamine, 0.5% non-essential amino acids, 0.05mM b-mercaptoethanol, 0.5% penicillin, 60ng / mL bone morphogenetic protein, 150ng / mL leukocyte inhibitory factor, 120ng / mL stem cells factor, 40ng / mL epidermal growth factor and 15μmol / L ROCK inhibitor;
[0061] (2) Inducing primordial germ cells to form a follicle-like structure: transfer the primordial germ cells induced in step (1) to PF-m m...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com